Neurocrine Biosciences Other Non-Current Liabilities 2010-2025 | NBIX
Neurocrine Biosciences other non-current liabilities for the quarter ending March 31, 2025 were $0.182B, a 50.71% increase year-over-year.
- Neurocrine Biosciences other non-current liabilities for 2024 were $0.166B, a 56.35% increase from 2023.
- Neurocrine Biosciences other non-current liabilities for 2023 were $0.106B, a 257.91% increase from 2022.
- Neurocrine Biosciences other non-current liabilities for 2022 were $0.03B, a 141.46% increase from 2021.